[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 405,182
  • Shares Outstanding, K 94,448
  • Annual Sales, $ 824,500 K
  • Annual Income, $ -365,900 K
  • EBIT $ -68 M
  • EBITDA $ 305 M
  • 60-Month Beta 1.81
  • Price/Sales 0.47
  • Price/Cash Flow 1.09
  • Price/Book 1.14

Options Overview Details

View History
  • Implied Volatility 175.78% (+116.36%)
  • Historical Volatility 80.65%
  • IV Percentile 57%
  • IV Rank 23.01%
  • IV High 586.89% on 02/19/26
  • IV Low 52.89% on 08/12/25
  • Expected Move (DTE 5) 0.22 (5.15%)
  • Put/Call Vol Ratio 0.17
  • Today's Volume 182
  • Volume Avg (30-Day) 104
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 2,212
  • Open Int (30-Day) 1,636
  • Expected Range 4.07 to 4.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.11
  • Number of Estimates 2
  • High Estimate $-0.10
  • Low Estimate $-0.12
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) -83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.75 +14.40%
on 05/06/26
5.36 -19.96%
on 04/15/26
-0.48 (-10.06%)
since 04/08/26
3-Month
3.75 +14.40%
on 05/06/26
5.71 -24.87%
on 02/24/26
-0.83 (-16.21%)
since 02/06/26
52-Week
3.75 +14.40%
on 05/06/26
8.59 -50.06%
on 10/16/25
+0.26 (+6.45%)
since 05/08/25

Most Recent Stories

More News
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

SALT LAKE CITY, May 07, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate...

MYGN : 4.29 (+4.89%)
MYGN Q1 Deep Dive: Hereditary Cancer Strength, Launch Investments Pressure Margins

MYGN Q1 Deep Dive: Hereditary Cancer Strength, Launch Investments Pressure Margins

MYGN : 4.29 (+4.89%)
Myriad: Q1 Earnings Snapshot

Myriad: Q1 Earnings Snapshot

MYGN : 4.29 (+4.89%)
Myriad Genetics (NASDAQ:MYGN) Misses Q1 CY2026 Sales Expectations, Stock Drops 16.2%

Myriad Genetics (NASDAQ:MYGN) Misses Q1 CY2026 Sales Expectations, Stock Drops 16.2%

MYGN : 4.29 (+4.89%)
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business

Highl ights First quarter 2026 revenue of $200.4 million grew 2% year-over-year, reflecting stable test volume and 2% year-over-year growth in average revenue per test. First quarter...

MYGN : 4.29 (+4.89%)
Myriad Genetics Reports Tomorrow on Whether New Product Launches Gained Commercial Traction or Merely Potential

Barchart Research What to Expect from MYGN Earnings MYGN Generated May 4, 2026 Current Price $4.94 EPS Estimate $$-0.16 Consensus Rating Hold Average Move 18.41% Myriad Genetics Reports Tomorrow on Whether...

MYGN : 4.29 (+4.89%)
Myriad Genetics (MYGN) To Report Earnings Tomorrow: Here Is What To Expect

Myriad Genetics (MYGN) To Report Earnings Tomorrow: Here Is What To Expect

MYGN : 4.29 (+4.89%)
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight ® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic...

MYGN : 4.29 (+4.89%)
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026

SALT LAKE CITY, April 28, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings...

MYGN : 4.29 (+4.89%)
3 Small-Cap Stocks We Think Twice About

3 Small-Cap Stocks We Think Twice About

MYGN : 4.29 (+4.89%)
DNUT : 3.60 (-1.10%)
HG : 30.86 (+0.59%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 4.82
2nd Resistance Point 4.60
1st Resistance Point 4.44
Last Price 4.29
1st Support Level 4.07
2nd Support Level 3.85
3rd Support Level 3.69

See More

52-Week High 8.59
Fibonacci 61.8% 6.74
Fibonacci 50% 6.17
Fibonacci 38.2% 5.60
Last Price 4.29
52-Week Low 3.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.